Vertellus acquires Polyscope Polymers

Matt Dixon • Feb 04, 2022

Specialty materials manufacturer Vertellus has acquired Polyscope Polymers B.V., a global leader in specialty additives for coatings, electronics applications, and engineering polymers.


About Polyscope Polymers

Polyscope is a global leader in the development and production of styrene maleic anhydride (SMA®) copolymers necessary for product applications across the electronic, automotive and specialty coatings & ink markets. With its innovative technology and engineering capabilities, Polyscope is well-positioned to capitalize on growth in these expanding markets. Polyscope operates a state-of-the-art production facility strategically located in Geleen, The Netherlands, and serves as a key partner to more than 300 customers across over 35 countries.  

About Vertellus

Vertellus is a leading global manufacturer of specialty materials and key ingredients for fundamental consumer necessities. Vertellus technology can be found in personal care products, pharmaceuticals, medical devices, nutraceuticals, food & beverages, performance coatings and transportation additives. Headquartered in Indianapolis and founded in 1857, Vertellus has more than 1,300 employees across 15 international research and manufacturing facilities. 

CCD Partners’ role

Achim Mauruschat and Rüdiger Funke, senior advisors to CCD Partners, and others from the team at JF Chemical Associates, advised Polyscope’s management on this transformational project. CCD Partners introduced Achim and Rüdiger to Polyscope and provided support for the project.


John Van Hulle, CEO of Vertellus, commented:


“Polyscope adds a complementary portfolio of high-quality solutions, a track record of innovation and a world-class global platform in attractive end markets to Vertellus. Together we will serve our customers with a unique product offering and our shared value-driven approach. I am pleased to welcome the Polyscope team to Vertellus.”  



Achim Mauruschat, Senior Advisor to CCD Partners, commented:

We were first selected to support management in identifying strategic options moving forward. Alongside Rothschild & Co., we have then provided advice and contents in the development of much of the material to position Polyscope in the best possible way for strategic options – emphasizing the strong potential of the company’s many solutions and activities. Futhermore, we have supported Polyscope in prioritizing and selecting final candidates as well as in identifying and promoting synergies with potential strategic partners.”

Patrick Muezers, Polyscope CEO, commented:


“Vertellus is the ideal partner to support the company’s next phase of growth and innovation. We will be able to leverage Vertellus’ global resources, capabilities and strong market leadership to better serve our customers and bring our high-quality products to additional customers throughout our markets.”

Thomas Chadwick, Principal at Pritzker Private Capital, commented:


“This highly strategic acquisition strengthens Vertellus’ global platform and positions the combined company for growth. We look forward to continuing to support the Vertellus and Polyscope teams as they serve customers with innovative, high-quality products and services.”

CCD Partners is a consultancy specialised in corporate transformations in small and mid-market chemicals and life sciences businesses.

To organise a call with one of our partners please email contact@ccdpartners.com

Receive M&A news relevant to your business

At critical moments our clients engage us to provide pre-publicity "off-market" intelligence to give them the edge over the competition - we also provide up-to-the-minute public or "on-market" intelligence for free

Contact Us

We're committed to your privacy. CCD Partners uses the information you provide to us to contact you about our relevant content, products, and services. You may unsubscribe at any time. For more information, please see our Privacy Policy.   

RECENT POSTS

By Matt Dixon 05 Dec, 2022
Market leading provider of formulated chemical process aids and foam control, PennWhite has been acquired by Manali Petrochemicals, part of the AM International Holdings group.
By Matt Dixon 02 Dec, 2022
Global source of industrial gas news, views, and debate, gas world has been sold by John and Karen Raquet to the senior management team in an MBO, backed by Mobeus Equity Partners.
By Matt Dixon 13 Sep, 2022
Polyblend UK Ltd is one of the market leaders in PVC based polymers. We are experts in manufacturing a comprehensive range of liquid plastisol and dispersion systems, complemented by our Speciality Distribution business supplying plasticisers, resins and PVC additives.
By Matt Dixon 05 May, 2022
GFBiochemicals is a sustainable chemicals company that produces levulinic acid derivatives at commercial scale directly from biomass. Having perfected its technology, product, and certification, the company is entering a new phase of commercialization.
By CCD Partners 20 Apr, 2022
In the latest episode of the Chemical Transformations podcast , CCD Partners' Managing Partner Matt Dixon speaks with Ted Clark, former President and CEO of Royal Adhesives & Sealants, discussing his new book "Shipping Clerk to CEO: The Power of Curiosity, Will, and Self Directed Learning”. The book tells the story of Clark’s remarkable career journey from entry-level worker to CEO of a $240m chemical company by the age of 42.
By Matt Dixon 04 Feb, 2022
Esteve Química purchases one of the UQUIFA Group's two pharmaceutical fine chemicals plants in Barcelona.
By Matt Dixon 01 Nov, 2021
Biosynth Carbosynth is a fully hybrid Research Products, Life Sciences Reagents and Custom Synthesis and Manufacturing Services Company with global research, manufacturing and distribution facilities. They are the supplier of choice for many in the pharmaceutical, life science, food, agrochemical, cosmetic and diagnostic sectors and manufacture and source a vast range of chemical and biochemical products.
By CCD Partners 12 Oct, 2021
Steve Allin co-founded Charnwood Molecular with Phil Page in 1998. 22 years later, the business has evolved dramatically from its origins as a spinout of Loughborough University. Backed by a partnership with Synova Capital, the company is now preparing to move into a former AstraZeneca research facility and has already completed its first M&A deal, acquiring Aurelia Bioscience in summer 2021. CCD Partners’ Matt Dixon spoke with Steve about the journey from full-time academia to running a high-growth market leader.
By Matt Dixon 24 Sep, 2021
Aspire was founded in 2009. Aspire has an asset-light business model that focuses on R&D, business development and sales and marketing, while outsourcing manufacturing and distribution to specialist third parties. For more details see www.aspirepharma.co.uk.
By Dr Michelle Lynch 22 Jul, 2021
CCD Partners Senior Advisor Dr Michelle Lynch analyses the net zero roadmaps of five of Europe's leading speciality chemical companies, exploring the details of their strategies and evaluating the real-world impact of their commitments to climate neutrality.
Show More
Share by: